Section Arrow
Quote
INDV.NASDAQ
- Indivior Pharmaceuticals Inc.
Quotes are at least 15-min delayed:2026/05/19 03:14 EDT
Regular Hours
Last
 36.54
-0.22 (-0.60%)
Day High 
37.365 
Prev. Close
36.76 
1-M High
41 
Volume 
1.11M 
Bid
--
Ask
--
Day Low
36.2952 
Open
36.92 
1-M Low
31.23 
Market Cap 
4.35B 
Currency 美元 
P/E 18.74 
%Yield -- 
10-SMA 38.83 
20-SMA 36.51 
50-SMA 33.21 
52-W High 41 
52-W Low 11.065 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.95/2.47
Enterprise Value
4.66B
Balance Sheet
Book Value Per Share
-1.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
901.00M
Operating Revenue Per Share
8.48
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SBFMSunshine Biopharma Inc0.51+0.2259+79.51%-- 
HIMSHims & Hers Health22.29-2.76-11.02%-- 
ESPREsperion Therapeutics3.13+0.01+0.32%-- 
CGCCanopy Growth Corp0.9823-0.0577-5.55%-- 
VTRSViatris16.5+0.02+0.12%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.